Aim: The aim of this study was to assess the molecular subtype profiles of male breast
cancer (MBC) and subsequent clinical outcome using a validated 6-marker …

Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Although breast carcinomas share certain characteristics in both …

Male breast cancer (MBC) is a rare condition that accounts for 0.1% of all male cancers. Our
current evidence base for treatment is derived from female breast cancer (FBC) patients …

Male breast cancer (MBC) is rare and poorly characterized. Like the female counterpart,
most MBCs are hormonally driven, but relapse after hormonal treatment is also noted. The …

Molecular subtyping of breast cancer by gene expression has proven its significance in
females. Immunohistochemical surrogates have been used for this classification, because …

Context.—The rate of male breast cancer is a small fraction of that observed in females, thus
severely limiting our understanding of the pathogenesis of this condition. It remains unclear …

Background Breast cancer in men is an infrequent occurrence, accounting for~ 1% of all
breast tumors with an incidence of about 1: 100,000. The relative rarity of male breast cancer …

Abstract Introduction Male Breast Cancer (MBC) is a rare disease, about 1% of all breast
cancers worldwide and less than 1% of cancers occurring in men. The bilateral male breast …

Background Male breast cancer (MBC) is a rare malignancy. We aimed to analyze the
incidence trends, clinicopathological characteristics, and survival outcomes in early MBC …

Abstract Purpose of Review Male breast cancer is a relatively uncommon and rare disease
that is often managed based on evidence adopted from trials pertaining to female breast …